GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: TD-1792
Compound class:
Synthetic organic
Comment: Cefilavancin is the clinical lead from a series of glycopeptide-cephalosporin heterodimer antibacterial compounds, designed to treat serious infections caused by Gram-positive bacteria [2].
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Cefilavancin has potent activity against clinically relevant Gram-positive bacteria, including multidrug-resistant isolates. The MIC90 against methicillin-susceptible Staphylococcus aureus (MSSA) is 0.015 μg/ml and 0.03 μg/ml against methicillin-resistant S. aureus (MRSA) [1]. |